LGND icon

Ligand Pharmaceuticals
LGND

Overview Fund Activity

241 hedge funds and large institutions have $2.27B invested in Ligand Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 80 increasing their positions, 94 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
241
Holders Change
-10
Holders Change %
-3.98%
% of All Funds
4.28%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
31
Increased
80
Reduced
94
Closed
40
Calls
$33.1M
Puts
$173M
Net Calls
-$140M
Net Calls Change
-$33.2M

Top Buyers

1
State Street
State Street
Massachusetts
+$19.3M
2
Aberdeen Group
Aberdeen Group
United Kingdom
+$17.1M
3
Goldman Sachs
Goldman Sachs
New York
+$16.4M
4
CCMLC
Cardinal Capital Management LLC (Connecticut)
Connecticut
+$14.6M
5
William Blair Investment Management
William Blair Investment Management
Illinois
+$14.5M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$25.1M
2
BlackRock
BlackRock
New York
-$16.9M
3
CC
Chicago Capital
Illinois
-$15.2M
4
Citadel Advisors
Citadel Advisors
Florida
-$12.8M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$11.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
AssetMark Inc
276
AssetMark Inc
California
– -$1K -10 Closed
8 9 10 11
12